These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children. Schaad UB; Suter S; Gianella-Borradori A; Pfenninger J; Auckenthaler R; Bernath O; Cheseaux JJ; Wedgwood J N Engl J Med; 1990 Jan; 322(3):141-7. PubMed ID: 2403654 [TBL] [Abstract][Full Text] [Related]
7. [Reversible ceftriaxone-associated biliary pseudolithiasis in three children with renal diseases]. Zhong XH; Chen H; Yao Y; Zhuo XW; Huang JP; Xiao HJ; Ai Y Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):216-9. PubMed ID: 20426960 [TBL] [Abstract][Full Text] [Related]
8. Fasting and bed rest, even for a relatively short period, are risk factors for ceftriaxone-associated pseudolitiasis. Murata S; Aomatsu T; Yoden A; Tamai H Pediatr Int; 2015 Oct; 57(5):942-6. PubMed ID: 25907455 [TBL] [Abstract][Full Text] [Related]
10. Ceftriaxone-associated biliary sludge and pseudocholelithiasis during childhood: a prospective study. Bor O; Dinleyici EC; Kebapci M; Aydogdu SD Pediatr Int; 2004 Jun; 46(3):322-4. PubMed ID: 15151550 [TBL] [Abstract][Full Text] [Related]
11. Risk factors leading to ceftriaxone-associated biliary pseudolithiasis in children. Kong MS; Chen CY Changgeng Yi Xue Za Zhi; 1996 Mar; 19(1):50-4. PubMed ID: 8935375 [TBL] [Abstract][Full Text] [Related]
12. Ceftriaxone-associated biliary pseudolithiasis in children: do we know enough? Cuzzolin L; Oggiano AM; Clemente MG; Locci C; Antonucci L; Antonucci R Fundam Clin Pharmacol; 2021 Feb; 35(1):40-52. PubMed ID: 32492204 [TBL] [Abstract][Full Text] [Related]
13. Gallbladder and urinary tract precipitations associated with ceftriaxone therapy in children: a prospective study. Acun C; Erdem LO; Söğüt A; Erdem CZ; Tomaç N; Gündoğdu S; Cavuldak S Ann Trop Paediatr; 2004 Mar; 24(1):25-31. PubMed ID: 15005963 [TBL] [Abstract][Full Text] [Related]
15. [Pseudolithiasis caused by ceftriaxone in children: a case report]. Benedetti M; Zanchetta S; Bagnani A; Praderio R; Perbellini S; Melo C Pediatr Med Chir; 1995; 17(4):369-71. PubMed ID: 7491336 [TBL] [Abstract][Full Text] [Related]
16. Sonographic assessment of ceftriaxone-associated biliary pseudolithiasis in Chinese children. Meng D; Cao Y; Fu J; Chen R; Lu L; Tu Y J Int Med Res; 2010; 38(6):2004-10. PubMed ID: 21227004 [TBL] [Abstract][Full Text] [Related]
17. Early biliary pseudolithiasis during ceftriaxone therapy for acute pyelonephritis in children: a prospective study in 34 children. Bonnet JP; Abid L; Dabhar A; Lévy A; Soulier Y; Blangy S Eur J Pediatr Surg; 2000 Dec; 10(6):368-71. PubMed ID: 11215777 [TBL] [Abstract][Full Text] [Related]
18. Biliary pseudolithiasis in a child associated with 2 days of ceftriaxone therapy. Blais C; Duperval R Pediatr Radiol; 1994; 24(3):218-9. PubMed ID: 7936805 [TBL] [Abstract][Full Text] [Related]
19. Biliary precipitation during ceftriaxone therapy: frequency and risk factors. Soysal A; Eraşov K; Akpinar I; Bakir M Turk J Pediatr; 2007; 49(4):404-7. PubMed ID: 18246742 [TBL] [Abstract][Full Text] [Related]
20. Biliary pseudolithiasis in childhood: a case report. Herek O; Sarioğlu A; Koçer N; Tiryaki A; Akkemik B Eur J Pediatr Surg; 1999 Oct; 9(5):337-9. PubMed ID: 10584197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]